Japanese Encephalitis can be devastating
Keywords:
Japanese encephalitis; arboviruses; climate changes; mosquitos; vaccinationAbstract
Japanese encephalitis, caused by the JE virus transmitted by mosquitoes, is the most common type of epidemic encephalitis in Asia. It is endemic in most of South and Southeast Asia, but the number of cases can vary greatly between areas. While many infections do not lead to disease, the symptomatic cases can be very severe and life-threatening. It mainly affects children, whereas adults are generally immune to the disease due to either being infected in childhood or receiving vaccination. However, individuals who are not immune, such as travelers from non-endemic countries, are susceptible to the disease when exposed to the virus for the first time, regardless of age. Without antiviral treatment options, vaccination is the only strategy to establish effective protection against Japanese encephalitis.
References
1. Yun SI, Lee YM. Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother. 2014;10(2):263-79. doi: 10.4161/hv.26902. Epub 2013 Oct 25.
2. Turtle L, Easton A, Defres S, Ellul M, Bovill B, Hoyle J, et al. ‘More than devastating’-patient experiences and neurological sequelae of Japanese encephalitis§. J Travel Med. 2019 Oct 14;26(7):taz064. doi: 10.1093/jtm/taz064.
3. Solomon T, Ni H, Beasley DW, Ekkelenkamp M, Cardosa MJ, Barrett AD. Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol. 2003 Mar;77(5):3091-8. doi: 10.1128/jvi.77.5.3091-3098.2003.
4. Hegde NR, Gore MM. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease. Hum Vaccin Immunother. 2017 Jun 3;13(6):1-18. doi: 10.1080/21645515.2017.1285472.
Epub 2017 Feb 22.
5. Srivastava KS, Jeswani V, Pal N, Bohra B, Vishwakarma V, Bapat AA, et al. Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines. Vaccines (Basel). 2023 Mar 27;11(4):742. doi: 10.3390/vaccines11040742.
6. Auerswald H, Maquart PO, Chevalier V, Boyer S. Mosquito Vector Competence for Japanese Encephalitis Virus. Viruses. 2021 Jun 16;13(6):1154. doi: 10.3390/v13061154.
7. Solomon T, Dung NM, Kneen R, Thao le TT, Gainsborough M, Nisalak A, et al. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain. 2002 May;125(Pt 5):1084-93. doi: 10.1093/brain/awf116.
8. Deng X, Yan R, Li ZQ, Tang XW, Zhou Y, He H. Economic and disease burden of Japanese encephalitis in Zhejiang Province, 2013-2018. PLoS Negl Trop Dis. 2021 Jun 21;15(6):e0009505. doi: 10.1371/journal.pntd.0009505.
9. Moore SM. The current burden of Japanese encephalitis and the estimated impacts of vaccination: Combining estimates of the spatial distribution and transmission intensity of a zoonotic pathogen. PLoS Negl Trop Dis. 2021 Oct 13;15(10):e0009385. doi: 10.1371/journal.pntd.0009385.
10. Amicizia D, Zangrillo F, Lai PL, Iovine M, Panatto D. Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO®). J Prev Med Hyg. 2018 Mar 30;59(1):E99-E107. doi: 10.15167/2421-4248/ jpmh2018.59.1.962.
11. Ghosh D, Basu A. Japanese encephalitis-a pathological and clinical perspective. PLoS Negl Trop Dis. 2009 Sep 29;3(9):e437. doi: 10.1371/journal.pntd.0000437.
12. Hills SL, Stoltey J, Martínez D, Kim PY, Sheriff H, Zangeneh A, et al. A case series of three US adults with
Japanese encephalitis, 2010-2012. J Travel Med. 2014 SepOct;21(5):310-3. doi: 10.1111/jtm.12127. Epub 2014 May 26.
13. Tiwari S, Singh RK, Tiwari R, Dhole TN. Japanese encephalitis: a review of the Indian perspective. Braz J Infect Dis. 2012 Nov-Dec;16(6):564-73. doi: 10.1016/j. bjid.2012.10.004. Epub 2012 Nov 8.
14. Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K. Past, present, and future of Japanese encephalitis. Emerg Infect Dis. 2009 Jan;15(1):1-7. doi: 10.3201/ eid1501.080311.
15. Vannice KS, Hills SL, Schwartz LM, Barrett AD, Heffelfinger J, Hombach J, et al.; Japanese encephalitis vaccination experts panel. The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control. NPJ Vaccines. 2021 Jun 15;6(1):82. doi: 10.1038/s41541-021-00338-z.
16. Wadman M. Rude awakening. Science. 2023 Nov 24;382(6673):872-877. doi: 10.1126/science.adn0008. Epub 2023 Nov 23.
17. McGuinness SL, Muhi S, Britton PN, Leder K. Japanese Encephalitis: Emergence in Australia. Curr Infect Dis Rep. 2023 Jun 26; 25(6):111-122. doi: 10.1007/s11908-02300804-w.
18. NSW_Report, Summary of NSW Japanese encephalitis virus serosurvey results. 2022(September 2022 © NSW Health.SHPN (HP NSW) 220813).
19. Pavli A, Maltezou HC. Travel-acquired Japanese encephalitis and vaccination considerations. J Infect Dev Ctries. 2015 Sep 27;9(9):917-24. doi: 10.3855/jidc.5108.
20. Buhl MR, Lindquist L. Japanese encephalitis in travelers: review of cases and seasonal risk. J Travel Med. 2009 MayJun;16(3):217-9. doi: 10.1111/j.1708-8305.2009.00333.x. Erratum in: J Travel Med. 2009 Nov-Dec;16(6):412.
21. Murty US, Rao MS, Arunachalam N. The effects of climatic factors on the distribution and abundance of Japanese encephalitis vectors in Kurnool district of Andhra Pradesh, India. J Vector Borne Dis. 2010 Mar;47(1):26-32.
22. Tian HY, Bi P, Cazelles B, Zhou S, Huang SQ, Yang J, et al. How environmental conditions impact mosquito ecology and Japanese encephalitis: an eco-epidemiological approach. Environ Int. 2015 Jun;79:17-24. doi: 10.1016/j. envint.2015.03.002. Epub 2015 Mar 11.
23. Huits R, Eelen Y, Jorens PG, Ariën KK, Van Esbroeck M, Duval EL. Japanese encephalitis in a young traveler returning from a short-term holiday in Khao Lak, Thailand. Travel Med Infect Dis. 2020 Mar-Apr;34:101580. doi: 10.1016/j.tmaid.2020.101580. Epub 2020 Feb 11.
24. Huang GKL, Tio SY, Caly L, Nicholson S, Thevarajan I, Papadakis G, et al. Prolonged Detection of Japanese Encephalitis Virus in Urine and Whole Blood in a Returned Short-term Traveler. Open Forum Infect Dis. 2017 Sep 27;4(4):ofx203. doi: 10.1093/ofid/ofx203.
25. Rogers B, Bunn WB, Connor BA. An Update on Travel Vaccines and Issues in Travel and International Medicine. Workplace Health Saf. 2016 Oct;64(10):462-468. doi: 10.1177/2165079916633478. Epub 2016 Sep 28.
26. Ginsburg AS, Meghani A, Halstead SB, Yaich M. Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies. Hum Vaccin Immunother. 2017 Oct 3;13(10):2222-2231. doi: 10.1080/21645515.2017.1356496. Epub 2017 Aug 25.
27. Erra EO, Askling HH, Yoksan S, Rombo L, Riutta J, Vene S, et al. Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes. Clin Infect Dis. 2013 Jan;56(2):267-70. doi:
10.1093/cid/cis883. Epub 2012 Oct 16.
28. Kling K, Harder T, Younger Z, Burchard G, SchmidtChanasit J, Wichmann O. Vaccination against Japanese encephalitis with IC51: systematic review on immunogenicity, duration of protection and safety. J Travel Med. 2020 Mar 13;27(2):taaa016. doi: 10.1093/jtm/taaa016.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pier Luigi Lopalco, Luigi Roberto Biasio (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.